Press Releases

Data from a Clinical Study Evaluating GI Dynamics’ EndoBarrier to be Presented at IFSO

EndoBarrier ™ Gastrointestinal Liner Plus EndoBarrier Flow Restrictor Dramatically Increases Weight Loss in Obese Patients; Compelling Impact on Diabetes Risk Factors PARIS, France, August 26, 2009 – GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced...

read more

Novel Non-Surgical Therapy Dramatically Increases Weight Loss in Obese Patients; Results from Pilot Clinical Study Presented at ASMBS

EndoBarrier ™ Gastrointestinal Liner Plus Flow Restrictor Facilitates Substantial Excess Weight Loss; Median %EWL of 39.6 Percent Lexington, Mass., June 26, 2009 – GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced results from a pilot clinical study...

read more

New Clinical Data on GI Dynamics’ EndoBarrier™ Flow Restrictor to be Presented at the 26th Annual Meeting of the American Society for Metabolic and Bariatric Surgery

Company will also Exhibit at ASMBS; Booth #1017 Lexington, Mass., June 18, 2009 – GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that results from a pilot clinical study of the company’s EndoBarrier Gastrointestinal Liner in combination with a new...

read more

GI Dynamics’ EndoBarrier™ Gastrointestinal Liner to be Highlighted at Several Prominent International Diabetes and Obesity Meetings

Lexington, Mass., June 3, 2009 – GI Dynamics, a leader in non-surgical, endoscopic approaches for the treatment of type 2 diabetes and obesity, today announced that its EndoBarrier Gastrointestinal Liner will be highlighted by leading experts in metabolic disorders and endoscopy at several...

read more

Weight Loss Data for EndoBarrier™ Technology Platform Presented at the Society of American Gastrointestinal and Endoscopic Surgeons 2009 Annual Meeting (SAGES)

Study Findings Show the EndoBarrier Liner Combined with the EndoBarrier Flow Restrictor Enhances Weight Loss Effect in a Porcine Model  Lexington, Mass., April 25, 2009 – GI Dynamics, a leader in non-surgical, endoscopic approaches for treating type 2 diabetes and obesity, today announced the...

read more

New Data on GI Dynamics’ EndoBarrier™ Technology Platform to be Presented at Upcoming Medical Meetings

EndoBarrier Technology Subject of Presentations at Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2009 Annual Meeting and the European Congress on Obesity (ECO) 2009 Meeting  Lexington, Mass., April 20, 2009 – GI Dynamics, a company pioneering devices to improve glycemic...

read more

GI Dynamics Closes an Additional $15 Million in Series C Financing

Lexington, Mass., February 19, 2009 – GI Dynamics today announced that it has closed an additional $15 million in Series C financing. With this additional funding, GI Dynamics has closed a total of $45 million in Series C financing, bringing the total raised by GI Dynamics since its inception to...

read more

GI Dynamics Receives ISO Certification and European CE Mark Approval for the EndoBarrier™ Gastrointestinal Liner System

Lexington, MA, January 7, 2009 – GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and metabolic disorders, today announced that it has received ISO 13485:2003 certification for the company’s Lexington facility. The company has also received...

read more

New Data in Journal Obesity Demonstrate that a Noninvasive, Removable Medical Device Results in Substantial Weight Loss and Glucose Normalization in a Preclinical Model of Obesity

Data Support Weight Loss and Glucose Results Observed in Clinical Trials of EndoBarrier™; Study Recognized by Obesity Society at 2008 Annual Meeting  LEXINGTON, Mass., November 18, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and type 2...

read more

GI Dynamics Announces Promising Multi-Center Safety and Efficacy Data of EndoBarrier™ Gastrointestinal Liner for Pre-Surgical Weight Loss

New Clinical Data Presented at IFSO Show Excellent Short Term Weight Loss Results in Morbidly Obese Patients Buenos Aires, Argentina, September 26, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and metabolic disorders, today announced...

read more
Page 17 of 18« First...10...1415161718